Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array

[1]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Lisanti,et al.  Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A. , 2001, American journal of physiology. Cell physiology.

[5]  D. Hilton,et al.  SOCS Proteins: Negative Regulators of Cytokine Signaling , 2001, Stem cells.

[6]  A. Yoshimura,et al.  Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line. , 2001, European journal of cancer.

[7]  S. Korsmeyer,et al.  Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals , 2001, Nature Genetics.

[8]  P. Unger,et al.  The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. , 2001, Cancer research.

[9]  G. Bepler,et al.  MCM2 - a promising marker for premalignant lesions of the lung: a cohort study , 2001, BMC Cancer.

[10]  H. Friess,et al.  DOC-2/hDab2 Expression Is Up-Regulated in Primary Pancreatic Cancer but Reduced in Metastasis , 2001, Laboratory Investigation.

[11]  N. Voelkel,et al.  Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene. , 2001, The European respiratory journal.

[12]  Xiang-Xi Xu,et al.  The adaptor molecule Disabled‐2 links the transforming growth factor β receptors to the Smad pathway , 2001, The EMBO journal.

[13]  J. Risteli,et al.  Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  D J Doolittle,et al.  Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  H. Kikutani,et al.  Knocking the SOCS off a tumor suppressor , 2001, Nature Genetics.

[16]  E. Avvedimento,et al.  The biological functions of A-kinase anchor proteins. , 2001, Journal of molecular biology.

[17]  E. Nishida,et al.  Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase , 2001, Nature.

[18]  S. Knuutila,et al.  Gene expression profiling of malignant mesothelioma cell lines: cDNA array study , 2001, International journal of cancer.

[19]  H. Dienemann,et al.  hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lung cancer susceptibility in a caucasian population , 2000, International journal of cancer.

[20]  O. Kallioniemi,et al.  Novel findings in gene expression detected in human osteosarcoma by cDNA microarray. , 2000, Cancer genetics and cytogenetics.

[21]  M. Wilkinson,et al.  Control of the eukaryotic cell cycle by MAP kinase signaling pathways , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  J. Fujita,et al.  Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines. , 2000, Lung cancer.

[23]  R. Parwaresch,et al.  Human DNA-Topoisomerases – Diagnostic and Therapeutic Implications for Cancer , 2000, Oncology Research and Treatment.

[24]  T. Rohan,et al.  Role of the insulin-like growth factor family in cancer development and progression. , 2000, Journal of the National Cancer Institute.

[25]  B. L. Riggs,et al.  Cytokine‐specific induction of the TGF‐β inducible early gene (TIEG): Regulation by specific members of the TGF‐β family , 2000 .

[26]  F. Khuri,et al.  Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. , 2000, Cancer research.

[27]  Mong-Hong Lee,et al.  Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression* , 2000, The Journal of Biological Chemistry.

[28]  H. Dosaka-akita,et al.  Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung , 2000, Cancer.

[29]  Sang Gyun Kim,et al.  Transcriptional inactivation of the tissue inhibitor of metalloproteinase‐3 gene by dna hypermethylation of the 5'‐CpG island in human gastric cancer cell lines , 2000, International journal of cancer.

[30]  Cheryl Schmidt,et al.  Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis , 2000, Oncogene.

[31]  M. Toyota,et al.  Quantitative DNA methylation analysis by fluorescent polymerase chain reaction single‐strand conformation polymorphism using an automated DNA sequencer , 2000, Electrophoresis.

[32]  R. Khokha,et al.  Differential expression of matrix metalloproteinases and their inhibitors in non‐small cell lung cancer , 2000, The Journal of pathology.

[33]  C. Tseng,et al.  The Role of DOC-2/DAB2 Protein Phosphorylation in the Inhibition of AP-1 Activity , 1999, The Journal of Biological Chemistry.

[34]  Joel H. Saltz,et al.  Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. , 1999, Cancer research.

[35]  B. Kazmierczak,et al.  A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas , 1999, Genes, chromosomes & cancer.

[36]  P. Miřejovský,et al.  Cytokeratins and lung carcinomas. , 1999, Ceskoslovenska patologie.

[37]  Christopher Haslett,et al.  Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo , 1999, Nature Medicine.

[38]  S. Hilsenbeck,et al.  Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. , 1999, Journal of the National Cancer Institute.

[39]  J. Couet,et al.  Reduction of caveolin 1 gene expression in lung carcinoma cell lines. , 1999, Biochemical and biophysical research communications.

[40]  S. Friedman,et al.  Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. , 1998, The Journal of biological chemistry.

[41]  J. M. Aerts,et al.  The Human Chitotriosidase Gene , 1998, The Journal of Biological Chemistry.

[42]  S. Friedman,et al.  Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Berkowitz,et al.  DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases , 1998, Oncogene.

[44]  J. Engelman,et al.  Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav‐1, ‐2, and ‐3) , 1998, FEBS letters.

[45]  A. Baldini,et al.  DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer , 1998, Oncogene.

[46]  S. Knuutila,et al.  DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma , 1998, Genes, chromosomes & cancer.

[47]  Yun Yen,et al.  Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential , 1998, Clinical & Experimental Metastasis.

[48]  A. Karameris,et al.  Association of expression of metalloproteinases and their inhibitors with the metastatic potential of squamous-cell lung carcinomas. A molecular and immunohistochemical study. , 1997, American journal of respiratory and critical care medicine.

[49]  H. Shiku,et al.  Transcription effect of nm23-M2/NDP kinase on c-myc oncogene. , 1997, Molecules and Cells.

[50]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[51]  T. Naka,et al.  Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. , 1997, Biochemical and biophysical research communications.

[52]  M. Polette,et al.  Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: Quantificative and morphological analyses , 1997, International journal of cancer.

[53]  D. Longo,et al.  Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. , 1997, Biochemical and biophysical research communications.

[54]  C. Vogel,et al.  Effect of transforming growth factor-beta1 on expression of aryl hydrocarbon receptor and genes of Ah gene battery: clues for independent down-regulation in A549 cells. , 1997, Molecular pharmacology.

[55]  R. Radulescu,et al.  Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. , 1997, Endocrinology.

[56]  H. Ackermann,et al.  Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer , 1997, Oncogene.

[57]  K. Green,et al.  Breaking the connection: displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly , 1996, The Journal of cell biology.

[58]  J. Siegfried,et al.  Detection of K-ras mutations in lung carcinomas: relationship to prognosis. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[59]  R. Swerlick,et al.  Identification and Characterization of a Novel Cytokine-inducible Nuclear Protein from Human Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[60]  F. Ciardiello,et al.  NM23 gene expression correlates with cell growth rate and S‐phase , 1995, International journal of cancer.

[61]  Genes, chromosomes & cancer , 1995 .

[62]  T. Karn,et al.  Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Gerretsen,et al.  L1210 cells selected for resistance to methoxymorpholinyl doxorubicin appear specifically resistant to this class of morpholinyl derivatives , 1994 .

[64]  M. Ridanpää,et al.  K‐ras mutations in human adenocarcinoma of the lung: Association with smoking and occupational exposure to asbestos , 1993, International journal of cancer.

[65]  M. Smith.  Histone structure and function. , 1991, Current opinion in cell biology.

[66]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[67]  K. Sikora,et al.  Leukemia , 1984, British Journal of Cancer.

[68]  C. Brigati,et al.  Tissue inhibitors of metalloproteases: Regulation and biological activities , 2004, Clinical & Experimental Metastasis.

[69]  L. Allen.  Stem cells. , 2003, The New England journal of medicine.

[70]  M Vihinen,et al.  Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion , 2001, Leukemia.

[71]  H. Bartsch,et al.  Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[72]  S. Zgleszewski,et al.  Fetal lung development: airway pressure enhances the expression of developmental genes. , 2000, Journal of pediatric surgery.

[73]  Michael J. Wilson,et al.  DAP12 and KAP10 (DAP10)-novel transmembrane adapter proteins of the CD3ζ family , 2000, Immunologic research.

[74]  J. Minna,et al.  Aberrant promoter methylation of multiple genes in non-small cell lung cancers. , 2001, Cancer research.

[75]  M. Saraste,et al.  FEBS Lett , 2000 .

[76]  I. Yada,et al.  Expression and degeneration of tenascin-C in human lung cancers. , 1998, British Journal of Cancer.

[77]  S. Knuutila,et al.  Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. , 1998, British Journal of Cancer.

[78]  K. Yasumoto,et al.  Elevated expression levels of the 14-3-3 family of proteins in lung cancer tissues. , 1997, Human antibodies.

[79]  M. Nissen,et al.  Cell cycle regulation and functions of HMG-I(Y). , 1995, Progress in cell cycle research.

[80]  M. Walshaw,et al.  Simple cytokeratins in the serum of patients with lung cancer: relationship to cell death. , 1994, European journal of cancer.

[81]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.